Adani Enterprises announced that Adani Wilmar (AWL) filed the red herring prospectus with Registrar of Companies (RoC), Gujarat on 19 January 2022 and it has been approved by by RoC on 20 January 2022. The issue comprises of a fresh issue of new equity shares of face value of Rs 1 by AWL for an amount up to Rs 3600 crore (including reservation for certain […]
Firstsource Solutions has allotted 1,64,813 equity shares under ESOP on 19 January 2022. Powered by Capital Market – Live News
Wipro has been recognized by the Top Employers Institute as a Top Employer in Singapore for 2022. The Top Employers Institute programme certifies organisations based on the participation and results of their HR Best Practices Survey. The survey covers six HR domains consisting of 20 topics including People Strategy, Work Environment, Talent Acquisition, Learning, Well-being and Diversity & Inclusion and more. The programme has certified […]
Strides Pharma Science today announced its partnership with Medicines Patent Pool (MPP) to commercialize molnupiravir in the international markets. Strides and its subsidiary, Universal Corporation (Kenya), have entered into a voluntary non?]exclusive sub?]license partnership with MPP covering 105 countries as part of MSD (NYSE: MRK, a trading name of Merck & Co., Inc, Kenilworth, NJ, USA) and MPP?fs partnership to enable a global reach for […]
G R Infraprojects has allotted 750 Unsecured, Rated, Listed Non-Convertible Debentures, of face value of Rs. 10,00,000 each, at an Issue Price of Rs. 10,00,000 each aggregating to Rs. 75 crore on Private Placement basis on 20 January 2022. Powered by Capital Market – Live News
Federal Bank has allotted 29,487 equity shares under ESOP on 20 January 2022. Powered by Capital Market – Live News
SMS Pharmaceuticals has received a non-exclusive license through the Medicines Patent Pool to manufacture molnupiravir, an investigational oral antiviral Covid- 19 medicine, to increase broad access of treatment in 105 low- and middle-income countries. Powered by Capital Market – Live News
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
